| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |